{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T19:41:51Z","timestamp":1694202111733},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.reuma.2011.05.011","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T16:48:44Z","timestamp":1312735724000},"page":"93-97","source":"Crossref","is-referenced-by-count":5,"title":["Osteoporosis premenop\u00e1usica: \u00bfc\u00f3mo tratarla?"],"prefix":"10.1016","volume":"8","author":[{"given":"Melania","family":"Mart\u00ednez-Morillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolors","family":"Grados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Holgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2011.05.011_bib0005","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Paper on Osteoporosis Prevention, Diagnosis and Therapy. JAMA. 2001;285:785\u201395.","DOI":"10.1001\/jama.285.6.785"},{"key":"10.1016\/j.reuma.2011.05.011_bib0010","unstructured":"World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. Geneva: WHO; 1994."},{"key":"10.1016\/j.reuma.2011.05.011_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.reuma.2009.01.014","article-title":"Osteoporosis en individuos j\u00f3venes","volume":"6","author":"Peris","year":"2010","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2011.05.011_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0025-7753(01)71732-0","article-title":"Prevalencia de osteoporosis determinada por densitometr\u00eda en la poblaci\u00f3n femenina espa\u00f1ola","volume":"116","author":"D\u00edaz Curiel","year":"2001","journal-title":"Med Clin"},{"key":"10.1016\/j.reuma.2011.05.011_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinical diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-1989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.05.011_bib0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S8756-3282(02)00778-0","article-title":"Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures","volume":"31","author":"Fiorano-Charlier","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.05.011_bib0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI117034","article-title":"Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model","volume":"93","author":"Matkovic","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.reuma.2011.05.011_bib0040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1359\/jbmr.1999.14.4.633","article-title":"Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort","volume":"14","author":"Rubin","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.05.011_bib0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","article-title":"Epidemiology and clinical features of osteoporosis in young individuals","volume":"15","author":"Khosla","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.05.011_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archinte.162.1.33","article-title":"Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures","volume":"162","author":"Wu","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.reuma.2011.05.011_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/sarh.2002.33725","article-title":"Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women","volume":"32","author":"Peris","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.05.011_bib0060","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","article-title":"Does treatment with bisphophonates endanger the human pregnancy?","volume":"30","author":"Djokan","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.reuma.2011.05.011_bib0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bone.2008.11.001","article-title":"Pregnancy outcome following in utero exposure to bisphophonates","volume":"44","author":"Levy","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.05.011_bib0070","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2005-2548","article-title":"Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of 4 cases","volume":"91","author":"Chan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.05.011_bib0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2010.03.002","article-title":"Bisphosphonates in patients with autoimmune rheumatic deseases: can they be used in women of childbearing age?","volume":"9","author":"Losada","year":"2010","journal-title":"Autoimmun Reb"},{"key":"10.1016\/j.reuma.2011.05.011_bib0080","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199412153312404","article-title":"Parathyroid hormone for prevention of bone loss induced by estrogen deficiency","volume":"331","author":"Finkelstein","year":"1994","journal-title":"N Eng J Med"},{"key":"10.1016\/j.reuma.2011.05.011_bib0085","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.reuma.2011.05.011_bib0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/8756-3282(96)00084-1","article-title":"Salmon calcitonin in the prevention of bone loss at perimenopause","volume":"18","author":"Arnala","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.05.011_bib0095","first-page":"408","article-title":"Osteoporosis asociada a hipercalciuria. Efecto del tratamiento con hidroclorotiazidas o etidronato c\u00edclico","volume":"28","author":"Peris","year":"2001","journal-title":"Rev Esp Reumatol"},{"key":"10.1016\/j.reuma.2011.05.011_bib0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00198-004-1716-0","article-title":"Idiopathic osteoporosis in premenopausal women","volume":"16","author":"Rubin","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.reuma.2011.05.011_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2565(08)71780-6","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica en la osteoporosis posmenop\u00e1usica, glucocorticoidea y del var\u00f3n. Sociedad Espa\u00f1ola de Investigaci\u00f3n \u00d3sea y del Metabolismo Mineral","volume":"208","author":"Gonz\u00e1lez Mac\u00edas","year":"2008","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.reuma.2011.05.011_bib0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/rheumatology\/34.8.742","article-title":"The effect of lupus erythematosus and long-term steroid therapy on bone mass in pre- menopausal women","volume":"34","author":"Pons","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.reuma.2011.05.011_bib0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"7","author":"Mazziotti","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.05.011_bib0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.genm.2010.06.004","article-title":"Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid","volume":"7","author":"Sugiyama","year":"2010","journal-title":"Gend Med"},{"key":"10.1016\/j.reuma.2011.05.011_bib0125","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomised trial","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.reuma.2011.05.011_bib0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","article-title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial","volume":"44","author":"Adachi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.05.011_bib0135","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.reuma.2011.05.011_bib0140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.reuma.2011.05.011_bib0145","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jcem-68-3-548","article-title":"Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa","volume":"68","author":"Biller","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.05.011_bib0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ajcn\/86.1.92","article-title":"Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses","volume":"86","author":"Dominguez","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.reuma.2011.05.011_bib0155","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2004-1659","article-title":"Alendronate for the treatment of osteopenia in anorexia nervosa: a randomised, double-blind, placebo-controlled trial","volume":"90","author":"Golden","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.05.011_bib0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1026508829397","article-title":"Clinical spectrum of primary hyperparathyroidism","volume":"1","author":"Bilezikian","year":"2000","journal-title":"Rev Endocr Metabo Disord"},{"key":"10.1016\/j.reuma.2011.05.011_bib0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.berh.2010.01.006","article-title":"Management of osteoporosis in a pre-menopausal woman","volume":"24","author":"Bhalla","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.reuma.2011.05.011_bib0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00054725-199811000-00002","article-title":"Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease","volume":"4","author":"Schulte","year":"1998","journal-title":"Inflam Bowel Dis"},{"key":"10.1016\/j.reuma.2011.05.011_bib0175","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00198-005-1911-7","article-title":"Absorption of oral bisphosphonate alendronate in osteoporotic patients with Crohn's disease","volume":"16","author":"Cremers","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.reuma.2011.05.011_bib0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","article-title":"Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation","volume":"350","author":"Shane","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.reuma.2011.05.011_bib0185","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","article-title":"Management of bone loss after organ transplantation","volume":"19","author":"Cohen","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.05.011_bib0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2265.1993.tb02398.x","article-title":"Pregnancy associated osteoporosis","volume":"39","author":"Dunne","year":"1993","journal-title":"Clin Endocrin"},{"key":"10.1016\/j.reuma.2011.05.011_bib0195","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00198-006-0112-3","article-title":"Bisphosphonate in pregnancy and lactation\u2013associated osteoporosis","volume":"17","author":"O'Sullivan","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.reuma.2011.05.011_bib0200","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/41.7.741","article-title":"Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density","volume":"41","author":"Minaur","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.reuma.2011.05.011_bib0205","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2003.016253","article-title":"Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density","volume":"63","author":"Lodder","year":"2004","journal-title":"Ann Rheum Dis"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X11001823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X11001823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T17:25:55Z","timestamp":1560446755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X11001823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1699258X11001823"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2011.05.011","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}